1. Two forms of hepatic pyruvate kinase, designated type L and type M, were distinguished on the basis ofkinetic, chromatographic, electrophoretic and immunological criteria. They were partially purified and their properties compared with each other and with the purified enzyme from skeletal muscle. 2. In contrast with type L, the type M enzyme showed no marked evidence of co-operative interactions with phosphoenolpyruvate and was not stimulated by fructose diphosphate. 3. The activity profiles of type L and type M enzymes were determined in developing rat liver by utilizing differences in the kinetic properties of the two forms. The high activity of type M enzyme in the early foetal rat decreased in late gestation and immediately after birth to reach a low value, which remained essentially constant for the remainder of the developmental period. The activity of type L enzyme, in contrast, was low in the early foetal and neonatal liver but increased markedly at the onset of weaning. 4. Possible roles of the two forms of hepatic pyruvate kinase in the control of glycolysis and gluconeogenesis are discussed.
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The pyruvate kinase (EC 2.7.1.40) activity in adult rat liver and the rate of hepatic glucose utilization respond in a similar manner to changes in the diet (Krebs & Eggleston, 1965; Tanaka et al., 1965; Yudkin & Krauss, 1967; Szepesi & Freedland, 1968; Bailey et al., 1968a) and hormonal status (Weber et al., 1965 (Weber et al., , 1966 . Tanaka et al. (1965) demonstrated that hepatic pyruvate kinase consists of more than one form. The major component, designated type L, is subject to control by both positive (phosphoenolpyruvate and fructose 1,6-diphosphate) and negative (ATP and alanine) effectors Tanaka et al., 1967a,b; Carminatti et al., 1968; Passeron et al., 1967; Bailey et al., 1968b; Carminatti et al., 1969; Seubert et al., 1968; Weber et al., 1968) . It is the activity of the type L hepatic enzyme that varies with dietary and hormonal conditions (Tanaka et al., 1965 (Tanaka et al., , 1967a two forms, again distinguished by sensitivity towards fructose 1,6-diphosphate, were also noted by Susor & Rutter (1968) . In view of these many reports, a summary of our own results on the type L enzyme will be given only as far as they are required for comparative purposes and estimation of the two forms.
The activity of the other main form of pyruvate kinase in liver, designated type M, whose properties are not well characterized, is relatively unchanged by dietary modifications (Tanaka et al., 1965 (Tanaka et al., , 1967a and appears to be related to the degree of differentiation ofthe organ; activity is increased in regenerating liver and certain hepatomas (Tanaka et a!., 1965; Suda et al., 1966) . The potential mechanisms for control of hepatic pyruvate kinase activity are thus both diverse and complex.
The increase in total hepatic pyruvate kinase activity (Walker & Vernon, 1967; Taylor etal., 1967; Vernon & Walker, 1968) during the weaning period parallels a rise in hepatic glucose-phosphorylating capacity that is known to be due to the synthesis of a unique.glucokinase (EC 2.7.1.2; Walker & Holland, 1965) . This suggested that an examination of the nature and the activities of the various forms of pyruvate kinase present at several stages of development might provide a more detailed understanding of the events involved in hepatic maturation, and the results are now reported.
Materials and Methods

Materials
Phosphoenolpyruvate (potassium salt), fructose 1,6-diphosphate, ATP, NADH, tris and muscle lactate dehydrogenase (EC 1.1.1.27) were obtained from Boehringer Corp. (London) Ltd., London W.5, U.K.; ADP and p-chloromercuriphenylsulphonic acid were from Sigma (London) Ltd., London S.W.6, U.K.; bovine serum albumin was from Armour Pharmaceutical Co. Ltd., Eastbourne, Sussex, U.K.; imidazole was from Eastman Kodak Co., Rochester, N.Y., U.S.A., and dithiothreitol was from Calbiochem, Los Angeles, Calif., U.S.A. All other chemicals were of AnalaR quality.
Animals
Rats were a Wistar albino strain fed ad lib. on a pellet diet. Litters were culled to a maximum of ten pups 2 days after birth and weanling rats were removed from their mothers when 30 days old. Neonatal animals were removed from such litters at random. Foetal age was assessed by the method of Stotsenburg (1915) . All adult animals were males weighing 200-250g.
Assay procedures
Homogenates (33%, w/v) were prepared in imidazole buffer (10mM), pH7.0, containing KCl (0.15M) and EDTA (2mM), and were centrifuged at 100000g for 50min. The supernatant fraction was used for all experiments. Pyruvate kinase was assayed at 30°C by a coupled assay system similar to that described by Reynard et al. (1961) . Except where modified for a particular purpose the final reaction mixture (lml) contained: imidazole buffer, pH7.0, 100mM; KCI, 100mM; MgCl2, 4.0mM; phosphoenolpyruvate, 1.0mM; ADP, 1.0mM; NADH, 0.15mM; bovine serum albumin, 0.5mg/ml; lactate dehydrogenase, 10 units. One unit of pyruvate kinase activity was defined as that which catalysed the formation of 1 umol of pyruvate/min at 30°C. Protein was determined in crude preparations by a biuret method (Gornall et al., 1949) and in more purified preparations by the method of Warburg & Christian (1941) . Protein in column eluates was monitored by absorption at 280nm.
Ammonium sulphate fractionations
These were performed at 0-40C by additions of finely ground ammonium sulphate to produce, in successive steps, fractions precipitating in the ranges 0-25, 25-45, 45-52 and 52-70% saturation. After each addition stirring was continued for 30min and the precipitate then collected by centrifugation. Precipitates containing activity were redissolved in and dialysed for 2h against imidazole buffer (20mM), pH7.0, containing EDTA (2mM) before use in further studies.
Kinetic results
The concentrations of the solutions of phosphoenolpyruvate and ADP used for the determination of Km were checked enzymically. Inhibitors were preincubated with the enzyme for 3min at 30°C in the assay system minus phosphoenolpyruvate, which was then added to start the reaction. When experiments involved the inhibitory action of ATP, the concentration of Mg2+ was 12.5mM. Fructose 1,6-diphosphate was added to the assay systemjust before the enzyme. All enzyme dilutions were made in imidazole buffer (20mM), pH7.0, containing bovine serum albumin (0.Smg/ml), and were used within 30min of dilution. Lactate dehydrogenase was in excess in all kinetic experiments.
Cellulose acetate electrophoresis
Cellulose acetate strips (17cm x 2.5cm) and the electrophoresis tank were obtained from Gelman Instrument Co. Ltd., Ann Arbor, Mich., U.S.A., and the procedure was essentially as described by Kohn (1960) . Samples for electrophoresis were dialysed against the electrophoresis buffer (70mM-sodium barbitone, pH 8.3, containing 1 mM-EDTA) for 3 h (two changes) before application. Constant portions (0.03 unit) of pyruvate kinase activity, usually contained in 2-4,ul, were applied to the strips 5.7cm from the cathode end under constant current (0.4mA/cm) and electrophoresis was continued for 2.5h at 40°C. The strips were stained for pyruvate kinase activity by incubation with thin strips of gelled assay system by a procedure similar to that employed by Susor & Rutter (1968) . The stain was examined under a Hanovia lamp (maximum emission at 366nm), when regions of enzymic activity became visible as dark bands on a fluorescent background.
Preparation ofanti-(muscle pyruvate kinase)
The purification of rat skeletal muscle pyruvate kinase followed the procedure described by Tietz & Ochoa (1962) as far as the second 55-70%-satd. ammonium sulphate fraction. The dissolved precipitate was passed through a column of Sephadex G-25 (Pharmacia, Uppsala, Sweden) equilibrated with acetate buffer (0.05M), pH 5.0, and the protein eluate adsorbed on a column of CM-cellulose equilibrated with this buffer. The enzyme was eluted at 75mM-KCl when a linear gradient (0-0.2M) of this salt was applied in the acetate buffer. A 63-fold purification was achieved with 48 % recovery ofactivity and the preparation had a final specific activity of 400 units/mg of protein.
The purified enzyme was dialysed for 12h against 0.85 % NaCl, adjusted to a protein concentration of 20mg/ml and emulsified with an equal volume of Freund's Complete Adjuvant (Difco Laboratories, Detroit, Mich., U.S.A.). Emulsion (1 ml) was injected into each foot pad ofa New Zealand white rabbit. This procedure was repeated after 2 weeks and followed by a booster dose (0.125ml) 2 weeks later. Blood was collected and antisera were prepared 10 and 17 1972 days after the last injection, as described by Leskowitz & Waksman (1960) . The antisera were purified by the procedure of Marrack et al. (1951) . Liver supernatants containing 0.2 unit of pyruvate kinase activity were preincubated with the antiserum as described by Susor & Rutter (1968) , except that preincubation with type M pyruvate kinase was for 5min only. Excess of antiserum did not inhibit the lactate dehydrogenase employed in the coupled assay system. Qualitative antigen-antibody analyses were performed by double diffusion in agar gel (Ouchterlony, 1949 Vol. of eluate (ml) Fig. 1 . Elution profile of the final stage in the partial purification of type M pyruvate kinase from rat liver by DEAE-cellulose chromatography The column was 13.5 cmx 2.2cm. The experimental procedure and the assay system are described in the text; 3-4ml fractions were collected.
, Enzyme activity (units/ml); ----, E280; -.-.-.-, concn. of KC1 in eluate.
Vol. 127 cellulose, and type M pyruvate kinase eluted at 17mM-KCl by applying a linear gradient (0-0.2M) of this salt in the above buffer (see Fig. 1 ). The final preparation, representing an eightfold purification and a 5.9% recovery of the activity in the 52-70%-satd. ammonium sulphate fraction, had a specific activity of0.51 unit/mg ofprotein. The poor recovery, which was due mainly to the instability of the enzyme on DEAE-cellulose, was not improved by the addition of either substrate to the buffer.
Results
Evidence for two forms ofhepaticpyruvate kinase Tanaka et al. (1965) first demonstrated heterogeneity of the enzyme by electrophoresis in starch blocks. Evidence for the presence of a second form that accompanies the predominating type of enzyme is presented here, based on (i) kinetic properties of fractions prepared by ammonium sulphate fractionation, (ii) DEAE-cellulose chromatography, (iii) electrophoresis on cellulose acetate strips, and (iv) immunological properties.
Ammonium sulphate fractionation. Initial experiments showed that pyruvate kinase activity could be precipitated over a wide range of the salt concentrations without signs of separated peaks of activity. Attention was eventually focused on the protein fractions that precipitated between the limits of 25-45% and 52-70% saturation with ammonium sulphate. With increasing concentrations of phosphoenolpyruvate, sigmoidal substrate-saturation curves were observed for each dialysed fraction and the K+ values for this substrate were similar. The values forn given by the slopes of Hill plots log[v/(Vmax.-v)] against log [phosphoenolpyruvate], however, were about 3 for the 25-45 %-satd. fraction and varied with different preparations between values of 1.3 and 1.8 for the 52-70%-satd. fraction. The value of n for the fraction precipitated between 45 and 70% saturation was higher (up to 2.5), suggesting that elimination of the activity precipitated between 45 and 52%-satd. ammonium sulphate from the 45-70 %-satd. fraction resulted in the removal of activity possessing properties similar to that precipitated between 25 and 45 %-satd. ammonium sulphate. The resultant fraction (52-70 %-satd.) showed essentially normal Michaelis-Menten kinetics with increasing concentrations of phosphoenolpyruvate.
Other properties of the enzyme present in the two ammonium sulphate fractions are given in fraction was not inhibited at this concentration but 13 % inhibition was observed at 0.25mM. The pyruvate kinase activity in dialysed preparations of the two fractions was inhibited to varying extents by very low (10-5-10-8M) concentrations of p-chloromercuriphenylsulphonic acid. Although quantitative relationships could not be established owing to the lack of purity of the preparations, it was observed that addition of fructose 1,6-diphosphate (final concn. 0.5mM) to the 25-45Y%-satd. fraction resulted in complete reversal of previous inhibition by p-chloromercuriphenylsulphonate.
Chromatography on DEAE-cellulose. Preliminary experiments indicated that not all the pyruvate kinase activity in a liver supernatant was bound to DEAE-cellulose (Whatman DE-32) at pH7.0. However, all the activity could be bound to this exchanger equilibrated with imidazole-chloride buffer (5mM), pH7.5, if the supernatant was first desalted (by a Sephadex G-25 column) and pretreated by passage 1972 through a column of CM-cellulose equilibrated with the same buffer.
Two peaks of activity (see Fig. 2 ), designated peak I and peak II respectively, were eluted at 0.02 and 0.074M-KCI. A steep gradient of KCl was necessary to prevent undue dilution of peak I and hence to permit accurate assay. Under identical conditions, the activity in a 25-45 %-satd. ammonium sulphate fraction was eluted in one symmetrical peak at 0.08M-KCI with 35% recovery of activity and one peak was eluted at 17mM-KCl from the 52-70%-satd. ammonium sulphate fraction with a 26% recovery. Assuming therefore the identity of the 25-45 %-satd. fraction with the peak II enzyme from the DEAE-cellulose column and of the 52-70%-satd. fraction with peak I enzyme, and making further allowances for the relative stabilities of the two enzyme forms, it can be calculated that peak I represents about 5% of the total original pyruvate kinase activity and peak II approx. 95 %. The inhibitory effects of ATP and Cu2l were also quantitatively very different (Table 1 ). The slope of the Hill plot for the effect of ATP on the peak II enzyme gave n = 2.5, which suggests that co-operative interactions may occur as ATP molecules bind to this enzyme. There were no reasons to doubt the apparent Vol. of eluate (ml) Fig. 2 . Separation of two peaks of pyruvate kinase activityfrom a pretreated liver supernatant by DEAE- cellulose chromatography The column was 13.0cm x 1.8cm and was equilibrated with imidazole buffer (5mM), pH7.5. Fractions (3-4ml) were collected and assayed as described in the text. , Enzyme activity (units/ml); ----, E280; -4-4-v-, concn. of KCl in eluate. Vol. 127 absence of sigmoidal kinetics with the peak I enzyme, but it should be noted that the peak II enzyme, prepared by column chromatography on DEAEcellulose, was partially desensitized with respect to inhibition by ATP compared with the enzyme in the 25-45 %-satd. ammonium sulphate fraction.
Electrophoresis on cellulose acetate strips. Two bands of enzymic activity were resolved from a rat liver supernatant with relative mobilities (muscle pyruvate kinase M = 1.0) of 1.3 and 0.7. The faster band stained more intensely than the slower. Neither presoaking the cellulose acetate strip with bovine serum albumin before electrophoresis (Rosalki & Montgomery, 1967) nor preincubation of the liver supernatant with fructose 1,6-diphosphate (2mM), EDTA (2mM) or dithiothreitol (1 mM) altered the staining pattern. Two bands of hepatic pyruvate kinase activity have also been detected by Pogson (1968a,b) and Susor & Rutter (1968) after electrophoresis on cellulose acetate.
The pyruvate kinase activity in peaks I and II from chromatography on DEAE-cellulose, concentrated by dialysis against polyethylene glycol, had different mobilities after electrophoresis on cellulose acetate. The peak II enzyme was almost identical in m value with the principal band of a liver supernatant and could not be resolved from it. Peak I pyruvate kinase activity had Rm = 0.9, but it was not possible to show conclusively on the strips that it was identical with the minor component of a liver supernatant.
Immunologicalstudies. Liver supernatant contained an antigen that cross-reacted with anti-(muscle pyruvate kinase); the addition of either EDTA or fructose 1,6-diphosphate did not alter this precipitin behaviour. The behaviour of a 52-70 %-satd. ammonium sulphate fraction was essentially identical with that of the liver supernatant but no precipitin band could be detected between the 25-45 %-satd. fraction and anti-(muscle pyruvate kinase) at concentrations of the former up to 4mg of protein/ml.
Properties of type L pyruvate kinase
Type L hepatic pyruvate kinase was prepared essentially by the method of Susor & Rutter (1968) . A 38-fold purification, giving a specific activity of 21 units/mg of protein, was achieved. The kinetic properties of this preparation (summarized in Table  2 ) are similar to those described by , Susor & Rutter (1968) and Carminatti et al. (1969) . The principal properties for purposes of comparison with the type M form (see the next section) were: (a) a sigmoidal saturation curve for phosphoenolpyruvate at several concentrations of ADP, with n = 3.5; (b) Michaelis-Menten hyperbolic kinetics with a Km for phosphoenolpyruvate (that was independent of the ADP concentration) of 5:5 I I 725 go 3.6xl05sM for the enzyme activated by fructose 1,6-diphosphate; (c) no inhibition by or precipitin reactions with anti-(muscle pyruvate kinase); (d) inhibition by ATP with half-maximum activity at 8.5 x 10-4M and n = 1.35, i.e. the slope of the Hill plot for the effect of ATP on the purified L-type enzyme appeared to be less than that for the peak II enzyme (see above). This desensitization towards ATP on purification has also been noted by Carminatti et al. (1969) .
Properties of type Mpyruvate kinase
About 25 % of the enzyme activity was lost during storage for 12h at 0°C in the preparative buffer. The rate of reaction in control assays (i.e. in the absence of either phosphoenolpyruvate or ADP) was low (<2%) and was unaltered by fructose 1,6-diphosphate. In marked contrast, very high rates were obtained when fructose 1,6-diphosphate was added to control assays containing the unpurified enzyme. These high rates are almost certainly due to the presence of an enzyme system that utilizes fructose as a substrate and ultimately results in the oxidation of NADH; they were allowed for in calculating the pyruvate kinase activities.
There are marked differences in the kinetic, chromatographic and immunological properties of type M and type L hepatic pyruvate kinase (Table 2) . This contrast was also noted by Tanaka et al. (1965 Tanaka et al. ( , 1967a . The type M enzyme exhibited normal Michaelis-Menten kinetics (n = 1.0) towards phosphoenolpyruvate, and the Km value for this substrate (Fig. 3) varied between 1.1 x 10-4 and 8.0x 10-4M when the pH of the preparative buffer was altered from 7.0 to 7.6. The Km was unaltered by the addition of fructose 1,6-diphosphate or by the concentration of the other substrate (Mg-ADP-). Apparent differences between our results and those of Tanaka et al. (1970) , who reported briefly some limited sigmoidal behaviour and partial activation of an unspecified preparation by fructose 1,6-diphosphate, may be related to the instability of the type M enzyme. The latter was not markedly inhibited by low concentrations of Cu2+ or p-chloromercuriphenylsulphonate.
In the presence of 12.5mM-Mg2+, the activity of type M pyruvate kinase was not significantly inhibited by concentrations of ATP up to 5mM. Inhibition at lower Mg2`concentrations was attributed to complex-formation of the added Mg2+ with ATP, which thus decreased the concentration of Mg-ADP-substrate (see, e.g., Wood, 1968) . The incomplete inhibition of the type M enzyme by anti-(muscle pyruvate kinase) may have been a consequence of the short incubation times (5min) that were necessary to prevent loss of activity in control and experimental samples. The type L enzyme was found not to be inhibited by the antiserum during incubation periods up to 1.5h.
There are marked similarities in the properties of type M hepatic pyruvate kinase and the enzyme from skeletal muscle (Table 2) , but small significant immunological and kinetic differences (e.g. Km value for phosphoenolpyruvate) were observed.
Activity of type L and type Mpyruvate kinase during development
The equivocal nature of the inhibition of total and type M hepatic pyruvate kinase activity by the anti-(muscle pyruvate kinase) preparation made it necessary to utilize (a) the differential behaviour towards Vol. 127 phosphoenolpyruvate and (b) inhibition by Cu2+ of the two enzymes to estimate their respective contributions to the total activities as follows.
(a) From Fig. 4 , which is constructed from the results obtained in Table 1 Fig. 5 . Thus from experimental measurements of the ratio vI/v2, the relative proportions of type L and M enzyme can be calculated.
(b) In the presence of concentrations of phosphoenolpyruvate and ADP that were optimum for both type L and type M enzyme, the rate v1 = VL+VM ,where VL and VM were as defined as above. In the presence of 1 mM-Cu2+ type L activity is inhibited completely (see Table 1 ) and type M by 30% (see Table 1 ), so that in the presence of this concentration of inhibitor v2 = 0.7 VM. Hence V2/v1 = 0.7(VM/ VL + VM).
The relative proportions of type L and M enzyme can thus be calculated from measurements of the ratio vl/v2. Liver supernatants were not dialysed before determination of v, and v2 in this method because dialysis alters the susceptibility of purified skeletal muscle enzyme to inhibition by Cu2+, and it is possible that preferential loss of one form of hepatic enzyme could occur during dialysis. No account was taken of endogenous effectors that could alter the degree of inhibition.
The above two methods were used to examine the effect of starvation of adult rats on the two forms and the results, which showed that it is only type L enzyme whose activity is decreased, were in agreement with those of Tanaka et al. (1965 Tanaka et al. ( , 1967a .
The separate activities of type L and type M enzyme were determined during the foetal and neonatal periods by the two methods. The development profiles (Fig. 6 ) obtained by both methods were qualitatively very similar, although there were small quantitative differences. The specific activity of the type M enzyme as determined by the phosphoenolpyruvate method (see Fig. 6 (Fig. 6) .
The development profile was not significantly altered when the results were expressed per lOOg body wt., except that the increase in activity of type L enzyme before birth was a little less than that depicted in Fig. 6 .
Discussion
Although the molecular nature of types L and M hepatic pyruvate kinase is not known, sufficient kinetic, chromatographic and electrophoretic differVol. 127 ences have been observed to suggest that the two forms are different. The limited immunological information suggests that they may be different proteins. If so, types L and M pyruvate kinase may be termed isoenzymes within the context of the definition of Latner & Skillen (1968) . Rutter (1969) has described a form of the enzyme in the late foetal liver that has electrophoretic behaviour between that of type L and type M enzyme. The possibility of molecular interconversions between type L and M enzyme cannot therefore be excluded. There are many similarities (Table 2 ) between the properties of the type M liver enzyme and the enzyme from skeletal muscle, but there do appear to be some immunological differences between them. Jimenez de Asu'a et al. (1971) have reported that they also differ with respect to their inhibition by phenylalanine and other amino acids.
The activity of type M pyruvate kinase in rat liver is unlikely to be caused by leucocyte contamination because, although leucocyte pyruvate kinase has properties similar to those of the type M hepatic enzyme (Campos et al., 1965) it has a low specific activity in the leucocyte, and perfusion of the liver to remove most of the blood does not alter the amount of type M enzyme detected. The kinetic properties of type M pyruvate kinase in the present study are in general agreement with those summarized by Tanaka et al. (1970) . The absence of marked co-operative interactions with phosphoenolpyruvate or stimulation by fructose 1,6-diphosphate in our preparation (n values a little above 1 for the 52-70 %-satd. ammonium sulphate fraction were, however, noted; see above and Table 1 ) could be a result of the purification procedure desensitizing the enzyme, but no stimulation by fructose 1,6-diphosphate was ever observed at any stage of the preparation. The small stimulation reported by Tanaka et al. (1970) might conceivably be due to contamination of their type M enzyme with type L; this cannot be decided in the absence of information on the purity of their enzyme.
The proportion of the total activity due to the activities of type L and M hepatic pyruvate kinase reported by Tanaka et al. (1965 Tanaka et al. ( , 1967a in adult Sprague-Dawley rats (67 and 33 % respectively) differ from the values obtained in our Wistar strain (95 and 5 % respectively). This may well reflect genuine differences between the strains, since Bartley et al. (1967) and Eggleston & Krebs (1969) have reported different total pyruvate kinase activities in various strains of rats.
The intracellular concentration of phosphoenolpyruvate (0.13mM; Burch, 1965; Williamson, 1966) is such that the activity of the type L pyruvate kinase will be very susceptible to changes in the concentration of fructose 1,6-diphosphate. It seems likely (see also Schoner et al., 1970; Llorente et al., 1970) II that the activity of this enzyme in vivo will be almost completely inhibited under conditions favouring gluconeogenesis by cellular concentrations of ATP and alanine. Under such conditions the activity of the type M enzyme, which is relatively unaffected by fructose 1,6-diphosphate or ATP, would probably remain at around 1-2,umol/min per g wet wt. of liver (depending on the actual K. value of the enzyme in vivo). Thus the residual available hepatic pyruvate kinase activity during gluconeogenesis, even assuming that type L enzyme is not active, could be significant compared with the overall rate of gluconeogenesis (2,tmol/min per g wet wt. of liver; Exton & Park, 1967) . If the pathways of glycolysis and gluconeogenesis are not compartmented at this level then, in the absence of any metabolic inhibitors of the type M enzyme, some recycling of phosphoenolpyruvate will occur. This may increase the sensitivity of the control system, as suggested by Newsholme & Gevers (1967) . Although this argument is of necessity based on several assumptions about the intracellular substrate concentrations and enzyme activities, it is apparent that the contribution of minor isoenzymes to the overall activity of rate-limiting enzymes cannot be omitted from theories of metabolic control. The activity of the type M enzyme is unaffected by the increase in carbohydrate content of the diet at weaning (Fig. 6) . The evidence for a high activity of type M pyruvate kinase in the early foetal liver is in accord with the qualitative observations of Rutter (1969) , who used cellulose acetate electrophoresis. The changes in activity of type M enzyme are similar to those of the hepatic hexokinases (Burch et al., 1963) except that the activity of type M pyruvate kinase decreases rapidly just before and after birth whereas the decrease in hexokinase activity is more gradual. As the decrease in activity of type M enzyme is approximately paralleled by the decrease in the proportion of haemopoietic cells during this period (Oliver et al., 1963) , the possibility arises that type M pyruvate kinase is localized in these cells. The results of Linder-Horowitz (1969) and Oliver et al. (1963) were used to calculate the number of haemopoietic cells in the developing rat liver. The correlation between the activity of type M enzyme and the number of haemopoietic cells was found to be very poor. It is therefore unlikely that type M enzyme is localized solely in these cells. Tanaka et al. (1967a) demonstrated that both type L and M hepatic pyruvate kinases were present in the parenchymal cells by means of a fluorescent-antibody technique.
The increase in total hepatic pyruvate kinase activity that occurs as the supply of carbohydrate increases at weaning (Walker & Vernon, 1967; Vernon & Walker, 1968 ) is due to a different type of enzyme adaptation from that effecting the increase in hepatic glucose-phosphorylating activity during this period. The latter is caused by the synthesis at weaning of a unique glucokinase (EC 2.7.1.2). For pyruvate kinase both isoenzymes are already present in the early foetal liver and it is the type L form that increases in parallel with glucokinase.
